Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × olaratumab × Clear all

NCT03086369 2022-06-28

A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer

Phase 1/2 Completed

184 enrolled 22 charts

Gastrointestinal

Pancreatic Neoplasms